139 related articles for article (PubMed ID: 10502047)
1. A comparison of cell phenotypes in hemimegalencephaly and tuberous sclerosis.
Arai Y; Edwards V; Becker LE
Acta Neuropathol; 1999 Oct; 98(4):407-13. PubMed ID: 10502047
[TBL] [Abstract][Full Text] [Related]
2. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study.
Hirose T; Scheithauer BW; Lopes MB; Gerber HA; Altermatt HJ; Hukee MJ; VandenBerg SR; Charlesworth JC
Acta Neuropathol; 1995; 90(4):387-99. PubMed ID: 8546029
[TBL] [Abstract][Full Text] [Related]
3. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis.
Wenzel HJ; Patel LS; Robbins CA; Emmi A; Yeung RS; Schwartzkroin PA
Acta Neuropathol; 2004 Aug; 108(2):97-108. PubMed ID: 15185103
[TBL] [Abstract][Full Text] [Related]
4. Giant cells in cortical tubers in tuberous sclerosis showing synaptophysin-immunoreactive halos.
Yamanouchi H; Ho M; Jay V; Becker LE
Brain Dev; 1997 Jan; 19(1):21-4. PubMed ID: 9071486
[TBL] [Abstract][Full Text] [Related]
5. Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis.
Johnson MW; Emelin JK; Park SH; Vinters HV
Brain Pathol; 1999 Jan; 9(1):45-54. PubMed ID: 9989450
[TBL] [Abstract][Full Text] [Related]
6. Evidence of abnormal differentiation in giant cells of tuberous sclerosis.
Yamanouchi H; Jay V; Rutka JT; Takashima S; Becker LE
Pediatr Neurol; 1997 Jul; 17(1):49-53. PubMed ID: 9308976
[TBL] [Abstract][Full Text] [Related]
7. Tubers from patients with tuberous sclerosis complex are characterized by changes in microtubule biology through ROCK2 signalling.
Ferrer I; Mohan P; Chen H; Castellsague J; Gómez-Baldó L; Carmona M; García N; Aguilar H; Jiang J; Skowron M; Nellist M; Ampuero I; Russi A; Lázaro C; Maxwell CA; Pujana MA
J Pathol; 2014 Jul; 233(3):247-57. PubMed ID: 24604753
[TBL] [Abstract][Full Text] [Related]
8. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.
Talos DM; Kwiatkowski DJ; Cordero K; Black PM; Jensen FE
Ann Neurol; 2008 Apr; 63(4):454-65. PubMed ID: 18350576
[TBL] [Abstract][Full Text] [Related]
9. Loss of the TSC2 product tuberin in subependymal giant-cell tumors.
Arai Y; Ackerley CA; Becker LE
Acta Neuropathol; 1999 Sep; 98(3):233-9. PubMed ID: 10483779
[TBL] [Abstract][Full Text] [Related]
10. Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology.
Crino PB; Trojanowski JQ; Dichter MA; Eberwine J
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14152-7. PubMed ID: 8943076
[TBL] [Abstract][Full Text] [Related]
11. Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex.
Kyin R; Hua Y; Baybis M; Scheithauer B; Kolson D; Uhlmann E; Gutmann D; Crino PB
Am J Pathol; 2001 Oct; 159(4):1541-54. PubMed ID: 11583980
[TBL] [Abstract][Full Text] [Related]
12. Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis.
Mizuguchi M; Kato M; Yamanouchi H; Ikeda K; Takashima S
Acta Neuropathol; 1997 Dec; 94(6):525-31. PubMed ID: 9444353
[TBL] [Abstract][Full Text] [Related]
13. Tuberous sclerosis: a primary pathology of astrocytes?
Sosunov AA; Wu X; Weiner HL; Mikell CB; Goodman RR; Crino PD; McKhann GM
Epilepsia; 2008; 49 Suppl 2():53-62. PubMed ID: 18226172
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis.
Mizuguchi M; Ikeda K; Takashima S
Acta Neuropathol; 2000 May; 99(5):503-10. PubMed ID: 10805093
[TBL] [Abstract][Full Text] [Related]
15. Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex.
Takahashi DK; Dinday MT; Barbaro NM; Baraban SC
Epilepsia; 2004 Dec; 45(12):1525-30. PubMed ID: 15571510
[TBL] [Abstract][Full Text] [Related]
16. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions.
Wolf HK; Normann S; Green AJ; von Bakel I; Blümcke I; Pietsch T; Wiestler OD; von Deimling A
Acta Neuropathol; 1997 Jan; 93(1):93-6. PubMed ID: 9006662
[TBL] [Abstract][Full Text] [Related]
17. Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study.
Park SH; Pepkowitz SH; Kerfoot C; De Rosa MJ; Poukens V; Wienecke R; DeClue JE; Vinters HV
Acta Neuropathol; 1997 Aug; 94(2):180-6. PubMed ID: 9255394
[TBL] [Abstract][Full Text] [Related]
18. CD34-immunoreactive balloon cells in cortical malformations.
Fauser S; Becker A; Schulze-Bonhage A; Hildebrandt M; Tuxhorn I; Pannek HW; Lahl R; Schramm J; Blümcke I
Acta Neuropathol; 2004 Oct; 108(4):272-8. PubMed ID: 15221338
[TBL] [Abstract][Full Text] [Related]
19. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia.
Mizuguchi M; Yamanouchi H; Becker LE; Itoh M; Takashima S
Acta Neuropathol; 2002 Oct; 104(4):418-24. PubMed ID: 12200630
[TBL] [Abstract][Full Text] [Related]
20. Infantile tauopathies: Hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma.
Sarnat HB; Flores-Sarnat L
Brain Dev; 2015 Jun; 37(6):553-62. PubMed ID: 25451314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
